Thank God Dr Pi’s not a stock analyst.. a buck a share !?.I think based on your analysis, and what others have said it appears a significant part of this move is to absorb IncellDx into Cytodyn and dilute the hell out of the shares doing it, thus enriching current representatives of IncellDx. I am surprised that 28 shareholders of Cytodyn are getting sucked into this. I wonder what they have been promised ?